Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib
Conditions
- Non Small Cell Lung Cancer
Interventions
- DRUG: BKM120 and Erlotinib
Sponsor
SCRI Development Innovations, LLC
Collaborators